Article
Comparing the effects of GBA variants and onset age on clinical features and progression in Parkinson's disease.
CNS neuroscience & therapeutics - 1 Feb 2024
Ren Jingru, Zhan Xiaoyan, Zhou Hao, Guo Zhiying, Xing Yi, Yin Hangxing, Xue Chen, Wu Jun, Liu Weiguo
Abstract excerpt
OBJECTIVE: Glucosylceramidase (GBA) variants and onset age significantly affect clinical phenotype and progression in Parkinson's disease (PD). The current study compared clinical characteristics at baseline and cognitive and motor progression over time among patients having GBA-related PD (GBA-PD), early-onset idiopathic PD (early-iPD), and late-onset idiopathic PD (late-iPD). METHODS: We recruited 88 GBA-PD,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
